Ota Fuchs
Impact in
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Iron Metabolism and Disorders
- Multiple Myeloma Research and Treatments
- Genetics top 5%
- Hemoglobinopathies and Related Disorders
Papers in
- Hematology 35
- Acute Myeloid Leukemia Research 22
- Multiple Myeloma Research and Treatments 11
- Genetics 13
- Hemoglobinopathies and Related Disorders 8
- Co-authors
- J NeuwirtJ BorováPřemysl PoňkaE NečasKateřina KuželováIuri MarinovZbyněk HrkalDana Grebeňová
In The Last Decade
Ota Fuchs
65 papers receiving 996 citations
Peers
Comparison fields: 5 of 96
- Hematology 444
- Genetics 211
- Molecular Biology 569
- Cancer Research 101
- Oncology 164
Countries citing papers authored by Ota Fuchs
This map shows the geographic impact of Ota Fuchs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ota Fuchs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ota Fuchs more than expected).
Fields of papers citing papers by Ota Fuchs
This network shows the impact of papers produced by Ota Fuchs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ota Fuchs. The network helps show where Ota Fuchs may publish in the future.
Co-authors
The 25 scholars most cited alongside Ota Fuchs, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 30 | |
| 2 | 2019 | 41 | |
| 3 | 2018 | 4 | |
| 4 | 2015 | 21 | |
| 5 | 2013 | 41 | |
| 6 | 2012 | 25 | |
| 7 | 2012 | 14 | |
| 8 | CCAAT/enhancer-binding protein alpha (CEBPA) polymorphisms and mutations in healthy individuals and in patients with peripheral artery disease, ischaemic heart disease and hyperlipidaemia. | 2010 | 6 |
| 9 | 2010 | 6 | |
| 10 | 2009 | 19 | |
| 11 | 2009 | 4 | |
| 12 | 2007 | 20 | |
| 13 | 2003 | 8 | |
| 14 | 2003 | 91 | |
| 15 | 2002 | 37 | |
| 16 | 2000 | 42 | |
| 17 | 1993 | 6 | |
| 18 | 1992 | 13 | |
| 19 | Effect of heme on globin messenger RNA synthesis. | 1981 | 5 |
| 20 | 1977 | 13 |
About Ota Fuchs
Ota Fuchs is a scholar working on Hematology, Genetics, Molecular Biology, Clinical Biochemistry and Immunology, having authored 67 papers that have together received 1.0k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (22 papers), Protein Degradation and Inhibitors (12 papers), Multiple Myeloma Research and Treatments (11 papers), Ubiquitin and proteasome pathways (8 papers), Histone Deacetylase Inhibitors Research (8 papers), RNA modifications and cancer (8 papers), Hemoglobinopathies and Related Disorders (8 papers) and Retinoids in leukemia and cellular processes (7 papers). The work is most often cited by research in Hematology (444 citations), Genetics (211 citations), Molecular Biology (569 citations), Cancer Research (101 citations) and Oncology (164 citations). Ota Fuchs has collaborated with scholars based in Czechia, Poland and Germany. Frequent co-authors include J Neuwirt, J Borová, Přemysl Poňka, E Nečas, Kateřina Kuželová, Iuri Marinov, Zbyněk Hrkal, Dana Grebeňová, Barbora Brodská and Tomáš Stopka. Their work appears in journals such as Blood, Cardiovascular & Haematological Disorders - Drug Targets, Leukemia Research, Blood Cells Molecules and Diseases and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.